Immix Biopharma Inc. (IMMX)
undefined
undefined%
At close: undefined
2.14
5.42%
After-hours Dec 13, 2024, 07:49 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -15.60M -8.23M -24.38M -1.15M -972.81K
Depreciation & Amortization 5.47K 2.13K 2.47K 2.32K 1.08K
Stock-Based Compensation 2.57M 624.07K 218.98K - -
Other Working Capital -781.56K -936.53K -284.97K 169.68K 58.74K
Other Non-Cash Items - 100.00K 118.16K 575.00K -84.50K
Deferred Income Tax - - 22.85M - -
Change in Working Capital 1.65M 195.21K -391.04K 165.85K 181.70K
Operating Cash Flow -11.37M -7.41M -1.59M -404.69K -790.03K
Capital Expenditures -52.09K - -802 - -7.31K
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - -802 - -
Investing Cash Flow -52.09K - -802 - -7.31K
Debt Repayment - - 200.00K - 1.05M
Common Stock Repurchased - -99.96K - - -
Dividend Paid - - - - -
Other Financial Acitivies -229.38K -56.72K - - -
Financial Cash Flow 15.46M 3.23M 18.85M - 1.05M
Net Cash Flow 4.07M -4.21M 17.25M -342.93K 271.69K
Free Cash Flow -11.42M -7.41M -1.59M -404.69K -797.34K